Arvinas加入迈克尔·J·福克斯基金会LITE和PPMI项目,共同推进针对帕金森病LRRK2靶点的新疗法研发

美股速递
Jun 04

Arvinas Holding Company LLC宣布加入迈克尔·J·福克斯基金会的LITE和PPMI两大研究项目,旨在加速开发针对帕金森病关键靶点LRRK2的创新疗法。这一合作将整合多方资源,推动前沿科学探索与临床转化进程,为帕金森病患者带来新的治疗希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10